Low versus high dose Botulinum Toxin A in Axillary Hyperhidrosis

ISRCTN ISRCTN05152123
DOI https://doi.org/10.1186/ISRCTN05152123
Secondary identifying numbers N0065149382
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
01/05/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J A A Langtry
Scientific

Department of Dermatology
Sunderland Royal Hospital
Kayll Road
Sunderland
SR4 7TP
United Kingdom

Study information

Study designRandomised controlled intra-individual single-blinded study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleLow versus high dose Botulinum Toxin A in Axillary Hyperhidrosis
Study objectivesTo compare the efficacy of fewer injections of a higher dose (5U) to the conventional practice of numerous smaller dose (2U) injections. We aim to compare the total amount and area of sweating of these two regimes and their comfort for the patient.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSigns and Symptoms: Axillary hyperhidrosis
InterventionHigher dose (5U) vs conventional practice of numerous smaller dose (2U) injections
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Botulinum Toxin A
Primary outcome measurePatient comparison of the total amount and area of sweating by gravimetric (weighing total amount of sweat) and starch-iodine (demarcating area of sweat) testing respectively between the axillae treated with 2U BTX-A per injection to that treated with 5U BTX-A
Secondary outcome measuresNot provided at time of registration
Overall study start date01/09/2004
Completion date01/03/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsApproximately 28 patients will be recruited
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/09/2004
Date of final enrolment01/03/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Sunderland Royal Hospital
Sunderland
SR4 7TP
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

City Hospitals Sunderland NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan